Prospective analysis of efficacy and safety of individualized administration of midazolam for sedation during bronchoscopy
- Conditions
- Patients undergoing diagnostic bronchoscopy
- Registration Number
- JPRN-UMIN000003971
- Lead Sponsor
- agoya University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Not provided
Patients with at least one of the following conditions are ineligible. 1) Patients with type II respiratory failure who take or need home oxygen therapy 2) Patients with obstructive sleep apnea syndrome who need positive airway pressure ventilation 3) History of myocardial infarction within 6 weeks 4) Having mental disorders unable to mutual understanding 5) History of grave drug allergic reaction or allergic reaction to midazolam 6) Acute angle-closure glaucoma 7) Neuromuscular disease (such as myasthenia gravis) 8) Patients who are taking 9) Pregnancy, breast feeding and suspected pregnancy 10) Inadequate for bronchoscopy 11) Patients whose participation in the trial is judged to be inappropriate by the attendeing doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.